<div id="readability-page-1"><p>In a report released yesterday, Brian Cheng from J.P. Morgan maintained a Buy rating on Roivant Sciences, with a price target of <span id="expert-recommendation-target">$35.00</span>. The company’s shares closed yesterday at $29.83.</p><h3>Claim 30% Off TipRanks</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with  Smart Investor Picks  </li></ul> <p>Cheng covers the Healthcare sector, focusing on stocks such as Revolution Medicines, Protagonist Therapeutics, and Roivant Sciences. According to TipRanks, Cheng has an average return of <span>7.9%</span> and a 53.93% success rate on recommended stocks. </p> <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Roivant Sciences with a $34.70 average price target, implying a 16.33% upside from current levels. In a report released on April 16, Piper Sandler also maintained a Buy rating on the stock with a $40.00 price target.</p></div>

ROIV

ARKG

LABU

<p>J.P. Morgan analyst Brian Cheng has maintained a Buy rating on Roivant Sciences (ROIV) with a price target of $35.00, while the stock closed at $29.83. The analyst consensus suggests a Strong Buy rating with an average price target of $34.70, indicating a potential upside of 16.33%. Piper Sandler also supports this with a Buy rating and a $40.00 price target.</p>

Tip Ranks

Roivant Sciences

iShares Biotechnology ETF

SPDR S&P Biotech

Ark Genomic Revolution ETF

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Direxion S&P Biotech Bull 3X

JPMorgan Chase

Revolution Medicines

Protagonist Therap

Piper Sandler Cos

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)

Roivant Sciences (ROIV) Gets a Buy from J.P. Morgan